Back to Search
MICHAEL REGAN, MD
MD
Surgery Physician
NPI: 1871508945Individual
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
H7814(TX)
Research & Publications (20)
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.
PMID 19280340·Breast Cancer Res Treat·2010
4-observational
Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials.
PMID 19633053·Ann Oncol·2010
8-other
A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial.
PMID 19531445·Fertil Steril·2010
4-observational
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.
PMID 19633051·Ann Oncol·2010
4-observational
A prospective study comparing outcomes after reconstruction in rheumatoid arthritis patients with severe ulnar drift deformities.
PMID 19483578·Plast Reconstr Surg·2009
4-observational
The preferences for outpatient clinic appointment reminders among rheumatology patients.
PMID 19590440·J Clin Rheumatol·2009
8-other
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
PMID 19584163·Clin Cancer Res·2009
4-observational
Detection of TMPRSS2-ERG fusion gene expression in prostate cancer specimens by a novel assay using branched DNA.
PMID 19647299·Urology·2009
8-other
Treatment selection for patients with metastatic renal cell carcinoma.
PMID 19402069·Cancer·2009
6-review
Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
PMID 19228531·J Am Coll Surg·2009
8-other
Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?
PMID 19474376·Radiology·2009
7-preclinical
Phase II study of sunitinib in men with advanced prostate cancer.
PMID 19403935·Ann Oncol·2009
3-trial
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
PMID 19561607·Nat Genet·2009
8-other
A systematic review of therapeutic interventions for pressure ulcers after spinal cord injury.
PMID 19236976·Arch Phys Med Rehabil·2009
1-meta
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.
PMID 19632176·Cell·2009
8-other
How are we doing in reviewing those new patients who need to be seen as early as possible? An audit of 264 consecutive new patients seen over 6 months in a university hospital in Ireland.
PMID 19208581·J Rheumatol·2009
8-other
Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
PMID 19549893·Cancer Res·2009
8-other
Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer.
PMID 19528373·J Clin Oncol·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6811 AUSTIN CENTER BLVD # 300
AUSTIN, TX 78731 - Phone
- (512) 346-8888
Quick Facts
- NPI
- 1871508945
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile